Merrimack Pharmaceuticals Financials

Merrimack Pharmaceuticals Stock Summary

Merrimack Pharmaceuticals competes with Amicus Therapeutics, Celldex Therapeutics, Puma Biotechnology, and Agios Pharm. Merrimack Pharmaceuticals, Inc. operates as a biopharmaceutical company. The company was incorporated in 1993 and is headquartered in Cambridge, Massachusetts. Merrimack Pharmaceuticals operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange.

Merrimack Pharmaceuticals Key Financial Ratios

Merrimack Financial Ratios Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Merrimack Pharmaceuticals's current stock value. Our valuation model uses many indicators to compare Merrimack Pharmaceuticals value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Merrimack Pharmaceuticals competition to find correlations between indicators driving Merrimack Pharmaceuticals's intrinsic value. More Info.Merrimack Pharmaceuticals is regarded third in return on equity category among its peers. It is regarded fourth in return on asset category among its peers . Comparative valuation analysis is a catch-all technique that is used if you cannot value Merrimack Pharmaceuticals by discounting back its dividends or cash flows. It compares the stock's price multiples to nearest competition to determine if the stock is relatively undervalued or overvalued.

Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators. You can also try the Alpha Finder module to use alpha and beta coefficients to find investment opportunities after accounting for the risk.

If you are still planning to invest in Merrimack Pharmaceuticals check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Merrimack Pharmaceuticals' history and understand the potential risks before investing.